GLP1ProviderCompare
NexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · databaseNexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · database

Head-to-head · verified 2026-08-05

Mochi Health vs. NovoCare Pharmacy (Wegovy): prices, fine print, and the honest verdict

A product decision wearing a price tag: NovoCare Pharmacy (Wegovy) fulfills the FDA-approved medication while the other sells compounded product — this page prices the trade instead of pretending it's one market.

Cheaper semaglutide: Mochi Health ($178/mo)FDA-approved product: NovoCare Pharmacy (Wegovy)
Mochi Health
Official site
joinmochi.com
Tirzepatide, all-in at 10 mg
$278/mo
Semaglutide, all-in
$178/mo
Membership fee
$79/mo, mandatory
Commitment
membership recurs monthly
Cancellation
cancel membership any time; recurs until cancelled
Pharmacy
company-owned compounding facility
First-year total (standing rate)
$3,336
Price evidence
Source-verified
Last verified
2026-08-05
NovoCare Pharmacy (Wegovy)
Official site
www.novocare.com
Tirzepatide, all-in at 10 mg
Not offered
Semaglutide, all-in
$349/mo
Brand medications
Wegovy injectable (all doses $349), Wegovy HD 7.2 mg ($399), Wegovy oral tablets ($149 intro)
Membership fee
None
Commitment
none
Cancellation
no subscription
Pharmacy
Novo Nordisk direct / retail partners
Price evidence
Source-verified
Last verified
2026-08-09

Tirzepatide pricing

Mochi Health: $278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership. NovoCare Pharmacy (Wegovy) routes patients to brand-name medication (Wegovy injectable (all doses $349), Wegovy HD 7.2 mg ($399), Wegovy oral tablets ($149 intro)): your medication cost is the manufacturer's self-pay rate (Zepbound $299–$449, Wegovy $349) or an insurance copay, plus any program fee.

Semaglutide pricing

On semaglutide, Mochi Health wins at $178 versus $349 all-in — $171/mo apart. Mochi Health: Semaglutide runs $178 a month all-in. NovoCare Pharmacy (Wegovy): Semaglutide runs $349 a month all-in at the standing rate ($199 on intro/plan terms).

Different products, not just different prices

NovoCare Pharmacy (Wegovy) fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while Mochi Health sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

Mochi Health: Source-verified (verified 2026-08-05); names its pharmacy — company-owned compounding facility. NovoCare Pharmacy (Wegovy): Source-verified (verified 2026-08-09); names its pharmacy — Novo Nordisk direct / retail partners. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Mochi Health: membership recurs monthly; cancel membership any time; recurs until cancelled; $79/mo membership recurs until cancelled. NovoCare Pharmacy (Wegovy): none; no subscription.

The numbers

Mochi Health: $278/mo verified all-in; NovoCare Pharmacy (Wegovy): brand fulfillment (Zepbound $299–$449 / Wegovy $349); semaglutide: Mochi Health $178 vs NovoCare Pharmacy (Wegovy) $349; verified floor $215 (NexLife); brand rails $349–$449. Basis: all-in monthly, 10 mg maintenance, capture-dated in the dataset.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: Mochi Health holds $278 on every rung (four-month titration: exactly $1,112). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

On semaglutide, Mochi Health prices at $178 against $349 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. Mochi Health's ranked figure is $278 ($199 medication + $79 mandatory membership); NovoCare Pharmacy (Wegovy) bills at manufacturer/insurance rates plus any stated program fee. 2 · Maintenance basis. Mochi Health is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. Mochi Health: standing $278, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Mochi Health: source-verified, read 2026-08-05; NovoCare Pharmacy (Wegovy): source-verified, read 2026-08-09. 5 · Pharmacy weighed. Mochi Health names company-owned compounding facility; NovoCare Pharmacy (Wegovy) names Novo Nordisk direct / retail partners — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Mochi Health: a mandatory $79/mo membership folded into our all-in figure; cancel membership any time; recurs until cancelled; commitment: membership recurs monthly. NovoCare Pharmacy (Wegovy): no membership — the medication figure is the billed figure; no subscription; commitment: none. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Mochi Health carries source-verified pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — company-owned compounding facility, owned facility. NovoCare Pharmacy (Wegovy) carries source-verified pricing (last read 2026-08-09); pharmacy disclosure is its strong suit — Novo Nordisk direct / retail partners, manufacturer direct. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Mochi Health-to-NovoCare Pharmacy (Wegovy) move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Mochi Health: shipping included; consultation video visits included in membership; video visit model. NovoCare Pharmacy (Wegovy): shipping included (or retail via savings card); consultation bring your own prescription; prescription required visit model; savings-card pickup at 70,000+ retail pharmacies as the mail-order alternative. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Mochi Health if the semaglutide line is cheaper here; you want a price that survives titration; unlimited included clinician and dietitian visits matter more than the last $60. Pick NovoCare Pharmacy (Wegovy) if only the FDA-approved product will do; you refuse membership fees on principle. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are IVIM Health at $278 (dose-scaled, $75 membership included); Found at $289 (flat, no membership); ShedRx at $289 (dose-scaled, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.

Quick answers

What's the real difference between Mochi Health and NovoCare Pharmacy (Wegovy)?

NovoCare Pharmacy (Wegovy) fulfills FDA-approved brand medication; the other sells compounded product that is not FDA-reviewed. Price, product risk, and legal stability all differ.

Who wins on semaglutide?

Mochi Health at $178/mo all-in versus $349.

Can I switch between them?

Yes — patients move between telehealth programs routinely; you'll complete the new program's intake and prescriptions restart there. If you're also switching molecule or from compounded to brand, loop in the prescriber; our switching guide covers the clinical side.

Do either charge membership fees?

Mochi Health: $79/mo, mandatory (included in our all-in figure). NovoCare Pharmacy (Wegovy): none.

Which is easier to cancel, Mochi Health or NovoCare Pharmacy (Wegovy)?

Mochi Health: cancel membership any time; recurs until cancelled NovoCare Pharmacy (Wegovy): no subscription Cancel in writing either way; memberships cancel separately.

Is there a brand alternative to both?

Yes — Zepbound at $299–$449 via LillyDirect/retail (about $350 on TrumpRx; ~$50 for newly eligible Medicare patients) and Wegovy at a flat $349: FDA-approved products whose prices now sit close enough to make the comparison real.